Skip to main content
. 2010 Jul 15;11(1):97. doi: 10.1186/1465-9921-11-97

Table 2.

Fibre type distribution, fibre area, fibre perimeter, CAF and CAFA for type I and type IIa fibres.

Healthy subjects (n = 12) Mild
COPD
(n = 8)
Moderate COPD
(n = 9)
Severe
COPD
(n = 6)
P-value
Proportion type I fibres (%) 78.3 ± 8.7 70.2 ± 11.4 74.5 ± 11.9 59.4 ± 9.5* 0.009
Proportion type IIa fibres (%) 20.2 ± 8.9 24.6 ± 10.6 22.6 ± 11.4 40.2 ± 7.6* 0.02
Proportion type IIx fibres (%) 0 1.0 ± 1.6 0.6 ± 1.1 1.2 ± 2.1 ns
Proportion type IIx-a fibres (%) 0 0.2 ± 0.3 0.3 ± 0.6 0.5 ± 0.7 ns
Proportion type I-IIa fibres (%) 1.5 ± 1.4 4.0 ± 6.4 2.0 ± 2.3 1.6 ± 1.4 ns
Perimeter type I fibres 330 ± 38 332 ± 60 295 ± 40 320 ± 87 ns
Perimeter type IIa fibres 380 ± 48 348 ± 56 274 ± 53* 303 ± 81 0,003
Area type I fibres (μm2) 7143 ± 1508 7315 ± 2471 5736 ± 1497 6557 ± 2901 ns
Area type IIa fibres (μm2) 9262 ± 2215 7711 ± 2427 4880 ± 1970* 5418 ± 2232 0,004
CAF type I fibres (μm) 6,8 ± 1,1 6,8 ± 2,6 5,2 ± 0,9* 5,1 ± 1,2* 0,006
CAF type IIa fibres (μm) 6,7 ± 1,9 6,3 ± 2,4 4,4 ± 0,8* 4,5 ± 1,0* 0,002
CAFA type I fibres 1,0 ± 0,1 1,1 ± 0,4 1,0 ± 0,3 0,9 ± 0,2 ns
CAFA type IIa fibres 0,8 ± 0,3 1,0 ± 0,3 1,1 ± 0,3 1,0 ± 0,3 ns

Data are presented as mean ± SD.

*Significant difference compared to healthy subjects.

n = number of test subjects; CAF = number of capillaries around a single fibre; CAFA = the ratio between CAF and the area of the muscle fibre; ns = not significant